

Okyo Pharma Ltd - Guernsey-based ophthalmology-focused bio-pharmaceutical company, currently developing OK-101 to treat dry eye disease - New shares w...


Okyo Pharma Ltd - UK-based ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease - Delays delisting fro...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.


(Alliance News) - Okyo Pharma Ltd on Tuesday said it has applied to the UK Financial Conduct Authority and the London Stock Exchange PLC to delist its...


(Sharecast News) - Ophthalmology-focused bio-pharmaceutical company OKYO Pharma said on Tuesday that it has applied to delist from the London Stock Ex...